LncRNA polymorphisms and urologic cancer risk.
Esmat Abdi1, Saeid Latifi-Navid1
1Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
Environmental and Molecular Mutagenesis
|February 18, 2022
Summary
Long non-coding RNA (LncRNA) polymorphisms may serve as biomarkers for urologic cancer risk and prognosis. Further research is needed to validate their clinical utility in diagnosis and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Urologic cancers, including prostate, bladder, and kidney cancers, represent a significant portion of all cancer diagnoses.
- Long non-coding RNAs (LncRNAs) are crucial regulators of cellular processes and are often dysregulated in cancer.
- Aberrant LncRNA expression and genetic variations (polymorphisms) are implicated in cancer development and progression.
Purpose of the Study:
- To review and summarize the role of LncRNA polymorphisms in urologic cancers.
- To explore the potential of LncRNA single nucleotide polymorphisms (SNPs) as biomarkers for cancer susceptibility, diagnosis, and prognosis.
- To discuss the impact of LncRNA SNPs on therapeutic response.
Main Methods:
- Literature review and summary of existing research on LncRNA polymorphisms in urologic cancers.
- Analysis of the association between LncRNA SNPs and cancer risk, clinical outcomes, and treatment response.
- Identification of potential biomarker applications for LncRNA SNPs.
Main Results:
- LncRNA polymorphisms can alter LncRNA structure, expression, and function, potentially influencing cancer susceptibility.
- Specific LncRNA SNPs may serve as predictive biomarkers for urologic cancer risk and prognosis.
- Genetic variations in LncRNAs can impact individual responses to cancer therapies.
Conclusions:
- LncRNA polymorphisms show promise as diagnostic and prognostic indicators for urologic cancers.
- Further large-scale prospective studies and meta-analyses are required to validate these findings.
- Investigating the functional mechanisms of LncRNA SNPs is essential for their clinical application.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
03:18Non-LTR Retrotransposons
12.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K
01:12Loss of Tumor Suppressor Gene Functions
5.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
01:05Single Nucleotide Polymorphisms-SNPs
16.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K